Genmab Adr (GMAB)

Nov 12, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 12, 2024

Nov 05, 2024

Genmab to Present at Jefferies London Healthcare Conference - GlobeNewswire Inc.

Nov 05, 2024

Oct 16, 2024

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance

Oct 15, 2024

Oct 08, 2024

GMAB or INCY: Which Is the Better Value Stock Right Now? - Yahoo Finance

Oct 08, 2024

Oct 08, 2024

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance

Oct 08, 2024

Sep 24, 2024

Market Resilience: Genmab ADR (GMAB) Finishes Weak at 24.14, Down -5.44 - The Dwinnex

Sep 24, 2024

Sep 19, 2024

GANDHIM.APPL Share Price Today Up 13% - Equitymaster

Sep 19, 2024

Sep 18, 2024

Glenmark Pharma Share Price Today Down 3% - Equitymaster

Sep 18, 2024

Sep 16, 2024

Post-Trade Analysis: Genmab ADR (GMAB) Climbs 1.55, Closing at 26.90 - The Dwinnex

Sep 16, 2024

Sep 04, 2024

Market Recap: Genmab ADR (GMAB)’s Negative Momentum, Closing at 27.41 - The Dwinnex

Sep 04, 2024

Aug 06, 2024

All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy - MSN

Aug 06, 2024

Aug 02, 2024

Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet - Yahoo Finance

Aug 02, 2024

Jul 25, 2024

GMAB vs. CSLLY: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 25, 2024

Jul 19, 2024

GMAB’s Stock Journey: What Investors Need to Know About Genmab ADR’s Performance - The InvestChronicle

Jul 19, 2024

Jul 17, 2024

Wall Street Analysts Believe Genmab (GMAB) Could Rally 52.33%: Here's is How to Trade - Zacks Investment Research

Jul 17, 2024

Jul 17, 2024

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024 - GlobeNewswire Inc.

Jul 17, 2024

Jul 12, 2024

ISS suggest Enhabit shareholders elect three AREX Capital nominees to board By Reuters - Investing.com

Jul 12, 2024

Jul 12, 2024

Antibody Drug Conjugates Market Insights 2018-2023 and - GlobeNewswire Inc.

Jul 12, 2024

Jul 11, 2024

AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock? - Zacks Investment Research

Jul 11, 2024

Jul 09, 2024

GMAB or TECH: Which Is the Better Value Stock Right Now? - Yahoo Finance

Jul 09, 2024

Jul 08, 2024

GMAB vs. TECH: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 08, 2024

Jun 30, 2024

PBYI vs. GMAB: Which Stock Should Value Investors Buy Now? - Yahoo Canada Shine On

Jun 30, 2024

Jun 30, 2024

Zacks.com featured highlights include Tap Genmab, KnowBe4, UserTesting, Enphase Energy and Gartner - Yahoo Lifestyle UK

Jun 30, 2024

Jun 28, 2024

Genmab (GMAB), AbbVie Lymphoma Candidate Gets Orphan Drug Tag - Yahoo Sport Australia

Jun 28, 2024

Jun 27, 2024

Zacks.com featured highlights Genmab, Hologic, ServiceNow and Splunk - Yahoo New Zealand News

Jun 27, 2024

Jun 27, 2024

Oncolytics Biotech Inc. (ONCY) Hit a 52 Week High, Can the Run Continue? - Yahoo New Zealand News

Jun 27, 2024

Jun 27, 2024

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance

Jun 27, 2024

Jun 27, 2024

AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag - Yahoo New Zealand News

Jun 27, 2024

Jun 26, 2024

GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo New Zealand News

Jun 26, 2024

Jun 24, 2024

Genmab A/S executes share buyback program - Investing.com India

Jun 24, 2024

Jun 24, 2024

Genmab advances share buy-back program - Investing.com India

Jun 24, 2024

Jun 20, 2024

Ratio Revelations: Genmab ADR (GMAB)'s Financial Metrics in the Spotlight – DWinneX - The Dwinnex

Jun 20, 2024

Jun 05, 2024

Truist Securities ups Genmab shares target By Investing.com - Investing.com

Jun 05, 2024

Jun 02, 2024

AbbVie (ABBV) Signs New Cancer/Immunology Deal With Frontier - Yahoo Lifestyle UK

Jun 02, 2024

May 29, 2024

Genmab ADR (GMAB)'s stock chart: A technical perspective – US Post News - US Post News

May 29, 2024

May 28, 2024

Genmab ADR (GMAB) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

May 28, 2024

May 21, 2024

Genmab completes $1.8 billion acquisition of ProfoundBio By Investing.com - Investing.com

May 21, 2024

May 08, 2024

Genmab AS Sponsored ADR (GMAB) Hits Fresh High: Is There Still Room to Run? - Yahoo Singapore News

May 08, 2024

May 07, 2024

Is Genmab (GMAB) Outperforming Other Medical Stocks This Year? - Yahoo Lifestyle UK

May 07, 2024

May 04, 2024

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Singapore News

May 04, 2024

May 03, 2024

500: Something went wrong - Investing.com

May 03, 2024

May 02, 2024

Genmab Announces Financial Results for the First Quarter of 2024 | GlobeNewswire by notified - NTB Kommunikasjon

May 02, 2024

May 02, 2024

Earnings call: Genmab reports strong Q1 growth, plans ProfoundBio acquisition - Investing.com

May 02, 2024

Apr 10, 2024

GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com

Apr 10, 2024

Apr 03, 2024

Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily

Apr 03, 2024